Skip to search formSkip to main contentSkip to account menu

norzimelidine

Known as: 3-(4-bromophenyl)-N-methyl-(3-pyiidyl)allylamine oxalate, norzimeldine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
Abstract: The nature of [3H]imipramine binding to human platelets was investigated. Desipramine and 5‐hydroxytryptamine (5‐HT… 
1988
1988
A number of tertiary and secondary homoallylic amines, i.e. (Z)- and (E)-4-(4-bromophenyl)-4-(3-pyridyl)-3-buten-1-ylamines, were… 
1986
1986
Abstract— Seventy‐five outpatients with major depressive disorder (RDC) were randomly referred to treatment with a dominant 5‐HT… 
Highly Cited
1985
Highly Cited
1985
Abstract: A number of 5‐hydroxytryptamine (5‐HT) uptake inhibitors have been shown to displace the binding of [3H)imipramine to… 
1985
1985
1 A series of substituted p‐aminophenethylamines and some related compounds were examined with regards to the inhibition of… 
1983
1983
Une observation chez un garcon de 34 mois. La mere, la grand-mere et une sœur presentent une intolerance au lait de vache. L… 
1983
1983
SummaryThe prevention by six reversible and selective monoamine oxidase-A (MAO-A) inhibitors (α-ethyltryptamine, harmaline, 4… 
1981
1981
A double‐blind comparison of zimelidine, a potent and fairly selective 5‐hydroxytryptamine (5‐HT) uptake inhibitor, and…